HR-Positive Breast Cancer: Toni's Patient Story

What happened, in summary

Toni S was 59 when she was diagnosed with triple-positive breast cancer in February 2021. She learned that this type of breast cancer is hormone receptor-positive and HER2-positive, and her oncologist explained that there were medicines that could target her cancer. That information helped, but the diagnosis still brought fear about whether she would live to see family milestones and continue caring for her disabled son. Toni’s treatment began with 6 rounds of chemotherapy, given once every 3 weeks. Each cycle left her feeling very sick from about day 2 through day 9 before the next round began. After chemotherapy, she had surgery to remove the tumor. Pathology found cancer in some lymph nodes, so treatment continued. She then received Kadcyla and radiation. After 12 rounds of Kadcyla, her body was worn down, and the overall treatment period had stretched from February 2021 to June 2022. Toni later started anastrozole to suppress estrogen. Ongoing side effects included neuropathy in her feet and joint pain. After treatment, she focused on nutrition, walking, lowering stress, and losing 70 pounds. Her story emphasizes not only treatment completion, but also the way cancer pushed her to rebuild daily life around health, movement, and recurrence prevention.